Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.
The DOI matches its Crossref record; 173 of the 174 references it cites were found in a registry or an index.
Abstract
Many studies have shown the central importance of the co-receptors CD28, inducible costimulatory molecule (ICOS) and cytotoxic T lymphocyte antigen 4 (CTLA4) in the regulation of many aspects of T-cell function. CD28 and ICOS have both overlapping and distinct functions in the positive regulation of T-cell responses, whereas CTLA4 negatively regulates the response. The signalling pathways that underlie the function of each of the co-receptors indicate their shared and unique properties and provide compelling hints of functions that are as yet uncovered. Here, we outline the shared and distinct signalling events that are associated with each of the co-receptors and provide unifying concepts that are related to signalling functions of these co-receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mouse and human T cells the dimeric transmembrane glycoprotein CD28 represents the most important co-stimulatory molecule.”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [4]
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [4]
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [4]
Citations
Cites
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914 · cited 1×
“CTLA4-deficient mice develop massive lymphoadenopathy, autoimmunity and early deat”
BackgroundLymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766 · cited 1×
“CTLA4-deficient mice develop massive lymphoadenopathy, autoimmunity and early deat”
BackgroundSH2 domains recognize specific phosphopeptide sequences
Zhou, S. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,631
TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
Rao, A., Luo, C., & Hogan, P. G. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.707 · Cited by 2,603
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222 · cited 1×
“Co-ligation of CTLA4 with TCR, or with TCR and CD28 or TCR and ICOS inhibits proliferatio”
Signal transduction by lymphocyte antigen receptors
Weiss, A., & Littman, D. R. (1994) · Cell · doi:10.1016/0092-8674(94)90334-4 · Cited by 2,089
Three-dimensional segregation of supramolecular activation clusters in T cells
Monks, C. R. F., Freiberg, B. A., Kupfer, H., Sciaky, N., & Kupfer, A. (1998) · Nature · doi:10.1038/25764 · Cited by 1,968
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,902
Research works printed but not linked: 7
- Marinari, B. et al. Vav cooperates with CD28 to induce NF-κB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1. Eur. J. Immunol. 32, 447–456 (2002). This study shows that dominant-negative forms of VAV can effectively block the induction of nuclear factor-κB (NF-κB) activation through a pathway that involves RAC1. · DOI · Paper page
- Ghaffari-Tabrizi, N. et al. Protein kinase C-θ, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells. Eur. J. Immunol. 29, 132–142 (1999). · DOI · Paper page
- Tuosto, L. et al. Mitogen-activated kinase kinase kinase 1 regulates T cell receptor- and CD28-mediated signaling events which lead to NF-κB activation. Eur. J. Immunol. 30, 2445–2454 (2000). · DOI · Paper page
- Dimitratos, S. D., Woods, D. F., Stathakis, D. G. & Bryant, P. J. Signaling pathways are focused at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family. Bioessays 21, 912–921 (1999). · DOI · Paper page
- Schneider, H., da Rocha Dias, S., Hu, H. & Rudd, C. E. A regulatory role for cytoplasmic YVKM motif in CTLA-4 inhibition of TCR signaling. Eur. J. Immunol. 31, 2042–2050 (2001). · DOI · Paper page
- Nakaseko, C. et al. Cytotoxic lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail. J. Exp. Med. 190, 765–774 (1999). · DOI · Paper page
- Tuosto, L. & Acuto, O. CD28 affects the earliest signaling events generated by TCR engagement. Eur. J. Immunol. 28, 2131–2142 (1998). · doi:10.1002/(sici)1521-4141(199807)28:07<2131::aid-immu2131>3.0.co;2-q
Cited by
Items 301–393 of 393
Qin, L., Hu, C., Zhao, Q., Wang, Y., Fan, D., Lin, A., Xiang, L., Chen, Y., & Shao, J.-Z. (2024) · eLife · doi:10.7554/elife.101932.3 · Cited by 5
TRIC-Based High-Throughput Screening Enables the Discovery of Small Molecule CD28 BindersPreprint
Calvo‐Barreiro, L., & Gabr, M. T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.27.656499 · Cited by 4
Duan, S., Li, C., Yan, F., Xia, Y., Shao, S., Chen, W., Xiao, Z., & Xu, G. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-05899-w · Cited by 4
Chun, K.-H., Park, Y.-C., Hwang, N., Yoon, B. K., Kim, J. W., & Fang, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-42238-3 · Cited by 4
Costimulatory receptors in the channel catfish: CD28 family members and their ligands
Quiniou, S. M. A., Bengtén, E., & Boudinot, P. (2024) · Immunogenetics · doi:10.1007/s00251-023-01327-3 · Cited by 3
“The most important costimulatory receptors expressed by T cells are CD28 and CTLA4 (also known as CD152; Rudd and Schneider 2003).”
Transcriptional reprogramming via signaling domains of CD2, CD28, and 4-1BB
Linhares, A. D. S., Sharma, S., Steinberger, P., & Leitner, J. M. (2024) · iScience · doi:10.1016/j.isci.2024.109267 · Cited by 4
“38,39 43 Importantly, the cytoplasmic tail of the coinhibitory receptor CTLA-4 also contains a similar motif, also mediating p85 binding, 44 and further ruling out a prominent role of this motif in costimulatory signaling.”
BackgroundT-cell signaling and immunopathologies
Rudd, C. E. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-010-0203-2 · Cited by 4
“In addition, co-receptors such as CD28 can amplify the immune response [18, 19].”
BackgroundSelf-citationBanana Lectin from Musa paradisiaca Is Mitogenic for Cow and Pig PBMC via IL-2 Pathway and ELF1
Degroote, R. L., Korbonits, L., Stetter, F., Kleinwort, K. J. H., Schilloks, M.-C., Amann, B., Hirmer, S., Hauck, S. M., & Deeg, C. A. (2021) · Immuno · doi:10.3390/immuno1030018 · Cited by 3
“With the inducible T-cell co-stimulator ICOS as higher abundant immune response protein in BanLec stimulated PBMC, we identified an important costimulatory molecule for T-cell proliferation and cytokine secretion [58].”
BackgroundInterdomain interactions in Grb2 revealed by the conformational stability and CD28 binding analysis
Ochi, S., Iiyama, M., & Oda, M. (2022) · Biophysical Chemistry · doi:10.1016/j.bpc.2022.106792 · Cited by 3
CD4/CD8–p56lck Induced T-Cell Receptor Signaling and Its Implications for Immunotherapy
Oroya, A., & Rudd, C. E. (2025) · Biomolecules · doi:10.3390/biom15081096 · Cited by 2
“In the case of CD28, we and others have defined key domains that promote CAR T-cell survival [9,11,86,87].”
Self-citationZhang, B., Muhetarijiang, M., Sun, X., Wu, Y., Justin, R., Li, Z., Chen, T., Zhou, D., & Hu, X. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm43846 · Cited by 3
Leavenworth, J. W., & Pauza, M. E. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.03.003 · Cited by 2
Kiba, T., & Yagyu, K. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.01.010 · Cited by 2
“ICOS is a CD28 (Cluster of Differentiation 28)-superfamily costimulatory molecule that is expressed on activated T cells (Rudd and Schneider, 2003).”
BackgroundAntagonism of CD28 blocks allergic responses in the ovalbumin-induced asthmatic model mice
Kuo, C.-Y., Huang, C.-Y., Chen, H. M., Chen, L., & Kuo, M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114071 · Cited by 3
Avolio, M., Caracciolo, S., Tosti, G., Vollero, L., Fiorentini, S., & Caruso, A. (2008) · Viral Immunology · doi:10.1089/vim.2007.0095 · Cited by 2
“Upon interaction with its ligands CD80 and CD86, CD28 transduces signals which, coupled with TCR signaling, promote proliferation and cytokine production (35).”
Kłudka-Sternik, M., Serafin, A., Darmochwał-Kolarz, D., Radej, S., Roliński, J., Leszczynska-Gorzelak, B., & Oleszczuk, J. (2011) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-010-0054-7 · Cited by 2
Acosta‐Ampudia, Y., Ojeda, G., Zafra, M. P., Bernardone, I. S., Sánchez, A., Dianzani, U., Portolés, P., & Rojo, J. M. (2011) · Inmunología · doi:10.1016/j.inmuno.2011.06.002 · Cited by 2
Jordan, S. C., & Toyoda, M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3993-8.00041-6 · Cited by 2
Wang, B., Yao, W., Zhang, L. J., Jiang, L., Pan, J., Chai, W., Huang, Z., Zuo, S., Li, Z., Wei, Y., et al. (2025) · BMC Veterinary Research · doi:10.1186/s12917-025-04761-5 · Cited by 1
“ICOS up-regulates T-cell function, while CTLA4 down-regulates T-cell function [37].”
Vinot, P.-A., Vigneron, J., Marsande, J., Levacher, B., Tchitchek, N., Klatzmann, D., & Bellier, B. (2026) · npj Vaccines · doi:10.1038/s41541-026-01379-y · Cited by 1
“Therapeutics targeting CTLA-4, such as the CTLA-4 – IgfusionproteinAbatacept ® ,haveshownef fi cacyinpromotingtolerance in autoimmunity and transplantation by blocking co-stimulation and inducingIDO 23,24 .”
T cell lymphomas: cancers of aberrant immune synapse signalling
Tauber, P. A., & Ruland, J. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01283-5 · Cited by 1
Li, J., Duan, S., You, W., Zhao, Y., Li, W., Xiao, Z., & Liu, J. (2026) · EJNMMI Research · doi:10.1186/s13550-026-01432-w · Cited by 1
“Our group mainly focuses on PET imaging targeting T cell co-stimulatory molecules, especially inducible T cell co-stimulator (ICOS, also known as CD278), a key member of the CD28 superfamily [17].”
Co-Receptors in the Positive and Negative Regulation of T-Cell Immunity
Schneider, H., & Rudd, C. E. (2008) · Springer eBooks · doi:10.1007/978-4-431-73884-8_8 · Cited by 1
Self-citationSignal Transduction Changes in T-cells with Aging
Fülöp, T., Dupuis, G., Fortin, C. F., & Larbi, A. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_35 · Cited by 1
Immune and Genetic Susceptibility in the Development of Cervical Cancer
Mora, B. (2016) · International Journal of Cancer and Clinical Research · doi:10.23937/2378-3419/3/3/1057 · Cited by 1
“The CTLA-4 gene, located on chromosome2 at band q33, plays an important role in the deregulation of T-lymphocyte effector cells [32,33].”
BackgroundSignal Transduction Changes in T Cells with Aging
Fülöp, T., Page, A. Y. L., Dupuis, G., Fortin, C. F., Witkowski, J. M., & Larbi, A. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_35 · Cited by 1
Hacia un tratamiento no empírico de la artritis reumatoide basado en su patogenia molecular
Moreno, J. G., Vázquez-Ortíz, G., López-Blanco, J. A., López-Romero, R., & Medina, F. (2008) · Reumatología Clínica · doi:10.1016/s1699-258x(08)71791-1 · Cited by 2
Management of Advanced Non–Small Cell Lung Cancer
Xia, B., & Herbst, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-48565-4.00006-0 · Cited by 1
An Introduction to CAR Immunotherapy
Balkhi, M. Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819573-4.00001-6 · Cited by 1
Dong, Y., Chen, C., Suo, B., Yue, X., Han, P., Zhou, Y., & Qiao, H. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00369 · Cited by 1
Role of the Hedgehog receptor Patched1 in the development and function of T lymphocytes
Michel, K. D. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3888
La molécula CD28 y su función en la activación de células T
Saavedra, D. (n.d.) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Elucidating the role of regulatory T cells in colorectal cancer progression
Besneux, M. (2015) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 2
Daga, N., Servaas, N. H., Kisand, K. E., Moonen, D. P. I., Arnold, C., Reyes‐Palomares, A., Kaleviste, E., Kingo, K., Kuuse, R., Ulst, K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.11.575022 · Cited by 1
The role of the thymic medulla in T cell development and tolerance induction
Cowan, J. E. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Brown, D. S. (2005) · eScholarship@UMassChan · doi:10.13028/eqwy-6j58
“Several reports have linked Vav1 activity to Cbl-b, an essential downstream regulator of CD28 costimulation(150, 151).”
BackgroundRegulation of effector/memory T cell activation by inducible co-stimulator (ICOS).
Franko, J. (2009) · OhioLink ETD Center (Ohio Library and Information Network)
Induction de lymphocytes T régulateurs humains par activation de la voie Notch
Vigouroux, S. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
Generation, Maintenance and Fate of T Follicular Helper Cells
Weber, J. P. (2013) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-4311
“19,1496-1498 69 Abbreviations C Abbreviations APC antigen-presenting cell Bcl-6 B cell lymphoma-6 BCR B cell receptor CCR7 C-C chemokine receptor type 7 CD cluster of differentiation CFA Complete Freund’s Adjuvant CFSE 5,6-carboxyfluorescein diacetate succinimidyl ester CTLA-4 cytotoxic T lymphocyte–associated antigen…”
BackgroundInfluentialRegulation of immune response by T cell co-signaling
Abe, R. (2005) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.28.21
Toward a Non-Empirical Treatment for Rheumatoid Arthritis Based on Its Molecular Pathogenesis
Moreno, J. G., Vázquez-Ortíz, G., López-Blanco, J. A., López-Romero, R., & Medina, F. (2008) · Reumatología Clínica (English Edition) · doi:10.1016/s2173-5743(08)70145-x · Cited by 1
Surfing the waves of the tide model of T cell co-stimulation
Marín-Díez, E., Martínez‐Forero, I., Melero, I., & Palazón, A. (2011) · Inmunología · doi:10.1016/j.inmuno.2011.09.001
CYTOTOXIC T LYMPHOCYTE ASSOCIATED MOLECULE -4 (CTLA-4) GENE POLYMORPHISMS IN OVARIAN CANCER PATIENTS
Naeimi, S., Bagheri, K., & Erfani, N. (2010) · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Kirmānshāh · doi:10.22110/jkums.v14i3.258
Cell signalling and feline immunodeficiency virus growth and latency
Chan, C. N. (2013) · Enlighten: Theses (The University of Glasgow)
Identification of genetic factors contributing to disease susceptibility in Multiple Sclerosis
Lorentzen, Å. R. (2006) · NORA - Norwegian Open Research Archives
NKG2D-vermittelte Lymphozytenaktivierung
Becker, J. C., Schrama, D., & L�hder, F. (2004) · Der Onkologe · doi:10.1007/s00761-004-0753-9
“Aktivierte Moleküle sind in gelber Schrift dargestellt.”
BackgroundInfluentialA study of the immunological synapses and kinapses formed by CD4 T cell subsets
Thauland, T. J. (2009) · doi:10.6083/m4rv0kp8
Immune regulation by allergen immunotherapy
Maazi, H., & Shirinbak, S. (2012)
Parker, G. A. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-47377-2_5
Ly, L. H. (2005) · OakTrust (Texas A&M University Libraries)
Molecular Basis for Treating Cutaneous Melanoma
Ernstoff, M. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00042-1 · Cited by 1
Defining and targeting combination immunotherapies in mouse models of cancer
Demane, F., & Demane, D. F. (2019) · UCL Discovery (University College London)
CTLA-4 et Toll-like récepteurs: de nouvelles cibles en immunothérapie
Bedel, R., Borg, C., & Saas, P. (2008) · Springer eBooks · doi:10.1007/978-2-287-36008-4_12 · Cited by 1
The Role of T-cell Costimulation in the Pathogenesis of Kawasaki Disease
Parsaud, L. (2019) · TSpace (University of Toronto)
Soto, I. D. V. (2021) · Buleria (Universidad de León) · doi:10.18002/10612/12813 · Cited by 1
The Concept of Co-Stimulatory Blockade in SLEplease remove Aff4
Hoi, A. Y.-B. (2021) · Springer eBooks · doi:10.1007/978-3-030-85161-3_6
Espagnolle, N. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
Haspot, F. (2004) · OpenGrey (Institut de l'Information Scientifique et Technique)
Signal Transduction Changes in T-Cells with Aging
Fülöp, T., Page, A. Y. L., Dupuis, G., Fortin, C. F., Witkowski, J. M., & Larbi, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-64597-1_35-1
Parker, G. A., & Papenfuss, T. L. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-47377-2_1
Fruman, D. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.739700984.793585934
A rare case report: ICOS and WIPF1 mutation together in a patientPreprint
Arık, E., Keskin, Ö., Cesur, M., Küçükosmanoğlu, E., & Baştürk, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1395601/v1
Editorial: T-Cell Signaling Networks in Health and Disease
Rudd, C. E., Mérida, I., & Hawse, W. F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.875580
Self-citationTuosto, L. (2018) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101843
Faculty Opinions recommendation of CD28 costimulation: from mechanism to therapy.
Tuosto, L. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726363559.793546230
Okkenhaug, K. (2005) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a000548.01
Ma, X. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738784119.793583429
Tuosto, L. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101843-1
Data from ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
Xiao, Z., Mayer, A. T., Nobashi, T. W., & Gambhir, S. S. (2023) · doi:10.1158/0008-5472.c.6511512
Data from ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
Xiao, Z., Mayer, A. T., Nobashi, T. W., & Gambhir, S. S. (2023) · doi:10.1158/0008-5472.c.6511512.v1
Biomarkers of Prediction of Immunotherapy and Updates on CTLA-4 Therapy
Sobhani, N., Roudi, R., D’Angelo, A., & Generali, D. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_165-1
Flatow, E. A. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2023.tde-19092023-142217 · Cited by 2
Cornaby, C., & O’Gorman, M. R. G. (2024) · Wiley eBooks · doi:10.1002/9781683674023.ch18
Qin, L., Hu, C., Zhao, Q., Wang, Y., Fan, D., Lin, A., Xiang, L., Chen, Y., & Shao, J.-Z. (2025) · eLife · doi:10.7554/elife.101932.2
Zhou, Q., Wu, S., & Kang, Y.-B. (2025) · International Journal of Neuroscience · doi:10.1080/00207454.2025.2529232
Wang, R. Z., Yang, F., & Sui, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.31.666261
Biomarkers of Prediction of Immunotherapy and Updates on CTLA-4 Therapy
Sobhani, N., Roudi, R., D’Angelo, A., & Generali, D. (2025) · Springer eBooks · doi:10.1007/978-3-032-00765-0_165
Bariana, M., McGuire, M., Tuckett, A. Z., Cassella, E., Anand, S. R., Anuncio, S. A., Mina, S., Avtalion, S., Lloren, M., Bogert, N. V., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.12.047 · Cited by 1
Crétel, E. (2010) · theses.fr (ABES) · doi:10.70675/508b16b8zb071z4b9dzb247z46983fdfdb82 · Cited by 1
Mécanismes moléculaires du syndrome néphrotique idiopathique acquis
Zhang, S. (2010) · theses.fr (ABES) · doi:10.70675/7a8ed829zb633z4ac8za158z640001049a7e
Aubatin, A. (2016) · theses.fr (ABES) · doi:10.70675/da39795dz4a85z4cdcz978bz36991b79a119
CD28 : nouvelles données sur un récepteur majeur de la costimulation lymphocytaire T
Morin, S. O. (2017) · theses.fr (ABES) · doi:10.70675/cb01635fz2f63z43e2zad0cz210485c4c5cf
Vinot, P.-A. (2018) · theses.fr (ABES) · doi:10.70675/8d700747z53d5z4ad2z91fbz840e35448ca7
Rôle de la Neuropiline-1 dans les fonctions effectrices des lymphocytes T CD8 antitumoraux
Leclerc, M. (2018) · theses.fr (ABES) · doi:10.70675/13aee211zad7bz4b07z9a5fz29b15750d99c
Normal and pathological functions of the T cell signaling protein, THEMIS, in CD4+ T cells
Yang, C. (2021) · theses.fr (ABES) · doi:10.70675/59026c4ezea46z4241za55azd03232fac9cd
Gao, S., Li, Z., Zhang, R., Zhu, X., Cheng, Y., Zhao, M., & Xu, Y. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105440
Wang, X., Zhang, Y., Bandala‐Sanchez, E., Herold, M. J., Naselli, G., Zhan, Y., Huntington, N. D., & Harrison, L. C. (2026) · Immunobiology · doi:10.1016/j.imbio.2026.153219
Guo, L., Ma, X., Ma, T., Yang, Z., Li, L., Liu, Y., Wang, J., Zhan, P., & Shen, Z. (2026) · Transplantation · doi:10.1097/tp.0000000000005897 · Cited by 1
Wang, R., Yang, F., & Sui, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0355964
“As phosphorylation of CD28 (UniProt P10747-1) at tyrosine 191 (pCD28) is essential for PI3K-AKT pathway activation and subsequent T cell proliferation [38,39], we assessed Gal-9’s effect on CD28 signaling.”
ICOS and CD28: similar or separate costimulators of T cells?
van Berkel, E. A. T. (2006) · Utrecht University Repository (Utrecht University)
Metadata
- Authors
- Rudd, C. E., & Schneider, H.
- Affiliations
- Hammersmith Hospital (GB)
- Corresponding author
- Rudd, Christopher E.
- ORCID
- Rudd, Christopher E.
- Venue
- Nature Reviews Immunology
- Published
- 2003-07
- Volume
- 3
- Issue
- 7
- Pages
- 544-556
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2001716606
- Cited by
- 392
- References
- 174
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 12 · 2023: 9 · 2022: 17 · 2021: 15 · 2020: 16 · 2019: 14 · 2018: 13 · 2017: 15 · 2016: 16 · 2015: 13 · 2014: 9 · 2013: 19 · 2012: 13
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD28, ICOS, CTLA-4, T cell activation, T cell costimulation, T cell tolerance, signaling pathways
- MeSH terms
- Abatacept, Amino Acid Sequence, Animals, Antigens, Differentiation, T-Lymphocyte, Humans, Molecular Sequence Data, Proto-Oncogene Proteins, T-Lymphocytes, Signal Transduction, NF-kappa B, Protein Serine-Threonine Kinases, CD28 Antigens, Immunoconjugates, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinase Kinases, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, MAP Kinase Kinase Kinase 1, Proto-Oncogene Proteins c-akt, Proto-Oncogene Proteins c-vav, Inducible T-Cell Co-Stimulator Protein, 3-Phosphoinositide-Dependent Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.